Natrol was founded in 1980 by Elliott Balbert, beginning its journey as a nutritional supplement company in the United States.
Balbert was not simply a passive founder. He remained closely involved in the supplement industry for decades and was serving as Natrol’s CEO when he testified before the U.S. House Committee on Government Reform in 2004 about the dietary supplement industry.
Over the following decades, Natrol expanded from a relatively focused supplement company into a broader vitamin, mineral and specialty nutrition business.
The company’s product portfolio eventually moved well beyond melatonin. Natrol developed products covering sleep, mood and stress, brain health, beauty, immunity and other areas of consumer wellness.
One important part of Natrol’s rise was its ability to build recognizable consumer brands rather than simply sell generic supplements.
The company organized its products around consumer health needs and invested heavily in areas where people were actively looking for solutions. This approach became particularly powerful in sleep.
By the mid-2010s, Natrol described itself as one of the leading U.S. manufacturers of vitamins and supplements and said it was distributing products internationally in more than 50 countries.
Aurobindo Pharma acquired Natrol in 2014. During Aurobindo’s ownership, Natrol continued expanding its product portfolio and market reach. Aurobindo later reported that Natrol’s revenues and profitability had expanded and that the company remained among the top 20 branded dietary supplement companies in the United States.
A major turning point came in 2020.
Aurobindo Pharma agreed to sell Natrol to New Mountain Capital and its affiliate Jarrow Formulas for $550 million in cash. At the time, Aurobindo disclosed that Natrol had generated $156.66 million in revenue for the financial year ended March 31, 2020.
That transaction is one of the clearest publicly documented financial milestones in Natrol’s history.
New Mountain subsequently brought Natrol and Jarrow Formulas together under a new wellness platform.
In 2022, Natrol and Jarrow Formulas became part of Vytalogy Wellness.
The idea was to create a broader consumer wellness company that could combine established supplement brands with manufacturing, scientific expertise and wider distribution. Vytalogy describes itself as a modern wellness company focused on science-backed vitamins, supplements and nutritional solutions.
New Mountain Capital remains the private-equity owner behind Vytalogy Wellness. Its portfolio page identifies Vytalogy as a current private-equity investment and lists Natrol’s investment date as November 2020.
As of 2026, Craig Shiesley is identified by New Mountain Capital as CEO of Vytalogy Wellness, having joined the company in September 2024.
Natrol’s corporate headquarters are associated with the Los Angeles area, while Vytalogy operates manufacturing and operational locations in the United States.
Current Vytalogy employment information identifies locations in Los Angeles, California; Boulder, Colorado; and Haslet, Texas. The Haslet facility is specifically described as a gummy manufacturing plant.
This is important because Natrol has historically emphasized U.S.-based manufacturing. Vytalogy has also described itself as having U.S.-based manufacturing.
However, it would be misleading to claim that every Natrol melatonin tablet or gummy is manufactured at one particular factory. The company’s public information does not provide a complete product-by-product manufacturing map.
Natrol’s international reach has changed over time. Company materials have variously described distribution in more than 40, 50 and 60 countries depending on the period being discussed.
Its 2020 acquisition announcement said Natrol products were distributed in more than 60 countries, while more recent company materials describe international distribution in more than 40 countries.
The difference likely reflects changes in the company’s active distribution network rather than a simple measure of whether Natrol is “available” somewhere.
What matters is that Natrol is no longer simply a U.S. supplement brand. It has built a meaningful international presence through retail, online and distributor channels.
One of Natrol’s biggest advantages is that it does not sell just one melatonin formula.
The brand offers several forms, including:
That means the ingredient list depends on the exact Natrol product.
One of the brand’s best-known products is Natrol Melatonin 10 mg Fast Dissolve.
The current strawberry fast-dissolve product lists 10 mg of melatonin per tablet. Its current ingredient panel includes dextrose, microcrystalline cellulose, cellulose gum, crospovidone, maltodextrin, glyceryl behenate, sucrose esters of fatty acids, gum arabic, beet root extract for color, silicon dioxide, flavoring, sucralose and menthol.
The exact formula can change by flavor and product version. For example, an NIH Dietary Supplement Label Database record for a Natrol 10 mg fast-dissolve citrus product lists xylitol, maltodextrin, cellulose gum, soy polysaccharides, dextrin, crospovidone, silicon dioxide, malic acid, modified food starch, natural flavors, stearic acid, beet root extract, magnesium stearate and citric acid.
This is an important detail that many supplement articles overlook:
There is no single “Natrol melatonin ingredient list.”
The formulation changes depending on the product.
Melatonin is a hormone naturally produced by the body, particularly at night. Supplemental melatonin is used to provide an additional dose of the same compound.
Natrol markets its melatonin products for occasional sleeplessness and sleep support. The company’s fast-dissolve product is designed to dissolve in the mouth without water.
The fast-dissolve format is primarily a delivery advantage, not proof that the product is medically stronger than every other melatonin supplement.
Convenience is one of the biggest reasons.
Someone who wakes up at night or is traveling may not want to keep water nearby. A tablet that dissolves in the mouth removes that small barrier.
It also gives Natrol a recognizable product format that helps distinguish the brand from ordinary swallowable tablets.
Gummies became another major part of Natrol’s strategy.
The company’s melatonin gummies have become particularly visible in online retail. Third-party Amazon sales estimates in 2026 show some Natrol 10 mg gummy listings generating tens of thousands of estimated monthly unit sales. These are estimates, not audited company revenue figures, so they should be treated as directional rather than official sales numbers.
This distinction matters because a product can have extremely high Amazon sales without the manufacturer publicly reporting exactly how much revenue it generates from that product.
Natrol’s marketing strategy has evolved considerably.
Rather than relying exclusively on traditional supplement advertising, the company has increasingly connected sleep with lifestyle, fitness, celebrities, wellness culture and social media.
One of Natrol’s strongest long-term marketing ideas has been the concept of a “Natrol Night.”
The company used this idea particularly when launching Natrol Kids Melatonin, presenting the product as part of a family bedtime routine rather than simply another supplement bottle.
This is clever consumer marketing because parents do not necessarily think in terms of “taking melatonin.” They think about bedtime.
Natrol positioned its product inside that existing routine.
Natrol also partnered with Barry’s, the high-energy fitness brand.
The campaign connected wellness goals, physical activity and better sleep, essentially extending the conversation from daytime fitness into nighttime recovery. Natrol’s announcement described Barry’s as a global fitness and lifestyle community.
The strategic idea was simple: people who care about working out also care about recovery.
Sleep became part of that recovery story.
Natrol has also used celebrity-driven social campaigns.
One example was an Ashley Tisdale “Back on Track” giveaway, promoted through Natrol’s social channels.
This type of campaign is less about explaining the chemistry of melatonin and more about putting the product into a recognizable lifestyle context.
For a consumer brand, that can be much more effective than a technical explanation of the ingredient.
Natrol’s marketing has continued to move toward the broader sleep-and-wellness category.
In 2026, Natrol launched Ultra Sleep and Ultra Energy in partnership with Calm and Michelle Monaghan, presenting the products around the idea of supporting the full sleep cycle and 24-hour wellness. The announcement cites Nielsen data for the 52 weeks ending March 28, 2026, supporting Natrol’s No. 1 U.S. melatonin positioning.
This is arguably one of Natrol’s most strategically important recent campaigns because Calm already owns a strong association with sleep, relaxation and mental wellness.
Natrol therefore gets to borrow some of that broader sleep ecosystem rather than competing only on “melatonin.”
Natrol’s position is not the result of one product.
It comes from a combination of brand recognition, distribution, product variety, manufacturing capabilities, retail presence and decades of consumer familiarity.
Natrol is strongly associated with one word:
Melatonin.
That is enormously valuable.
Consumers searching for melatonin are not necessarily looking for a complicated formula. Many want a familiar brand from a store they already trust.
Natrol has made melatonin available as:
This gives the company more opportunities to meet different consumer preferences.
Natrol has historically been available through major retail, health, grocery, drug and online channels.
That distribution matters because consumers often purchase supplements where they already shop.
A brand does not need to convince someone to visit a specialty store if the product is already sitting in front of them at a major retailer or online marketplace.
Natrol’s history in sleep supplements predates today’s enormous wellness boom.
By the time melatonin became a mainstream consumer category, Natrol already had decades of experience building products around the ingredient.
“Fast dissolve.”
“Strawberry.”
“Gummies.”
“No water necessary.”
These are simple benefits.
They do not require the consumer to understand pharmacology.
That is one of the reasons Natrol has been successful at turning a technical ingredient into an everyday consumer product.
Current third-party Amazon estimates provide another indication of Natrol’s strength.
In July 2026, two Natrol 10 mg melatonin gummy listings were each estimated at around 40,000 units sold per month on Amazon’s U.S. marketplace.
Again, these figures are estimates from a third-party analytics platform, not audited Natrol disclosures.
Still, they show how significant the brand’s online consumer demand can be.
Natrol competes in a crowded international melatonin market.
Because the user intent is usually straightforward, the strongest competitors are not necessarily companies that copy Natrol’s exact formula. They are brands competing for the same consumer searching for a recognizable melatonin supplement.
Some major competitors include:
Nature Made is one of the strongest competitors in the U.S. supplement market and has a broad presence in vitamins and dietary supplements.
Its scale, retail distribution and brand recognition make it a major alternative to Natrol.
OLLY has been particularly successful with gummies and lifestyle-oriented supplement marketing.
Its colorful packaging and consumer-friendly positioning appeal strongly to shoppers who view supplements as part of a modern wellness routine.
Vitafusion is another major gummy supplement competitor.
Its strength comes from making traditionally “serious” supplements easier to consume, which puts it directly against Natrol’s gummy strategy.
Zarbee’s is particularly relevant in sleep-support products and family wellness.
Its positioning around families and children creates overlap with parts of Natrol’s melatonin portfolio.
NOW is a major supplement company with a much broader product portfolio.
It competes with Natrol primarily through price, ingredient variety and a reputation among supplement-focused consumers.
Life Extension competes at the more science-oriented end of the supplement market.
Its appeal is different from Natrol’s mainstream consumer positioning, but consumers looking for melatonin can easily compare the two brands.
Solgar is another established international supplement brand with melatonin products and strong recognition among health-conscious consumers.
Together, these brands show why Natrol’s market position is meaningful: the company is not operating in an empty category. It has to compete with some of the biggest names in the global dietary supplement industry.
This is where online articles often become misleading.
Natrol does not currently publish a complete, audited annual revenue figure as a standalone public company.
The reason is simple: Natrol is part of Vytalogy Wellness, which is privately held under New Mountain Capital. Therefore, current Natrol-specific annual sales are not disclosed in the way a publicly traded company would report them.
One of the strongest publicly documented figures comes from Aurobindo Pharma’s 2020 disclosure.
Before selling Natrol, Aurobindo reported that Natrol generated $156.66 million in revenue for the financial year ended March 31, 2020. Aurobindo agreed to sell the business for $550 million in cash.
That gives us a solid historical benchmark.
It should not, however, be presented as Natrol’s current 2026 revenue.
Current third-party marketplace data indicates strong demand for Natrol melatonin.
For example, April 2026 estimates showed Natrol’s 10 mg gummies at approximately 40,000 estimated monthly units for one listing, while another major listing was also estimated at around 40,000 monthly units.
July 2026 data similarly placed two Natrol 10 mg gummy products at approximately 40,000 estimated monthly units each.
These numbers are useful for understanding product momentum, but they cannot be multiplied directly into company revenue because:
So the responsible conclusion is that Natrol remains a major melatonin brand with substantial consumer demand, but its exact 2026 company-wide revenue is not publicly disclosed.
Natrol’s success is a story of long-term category building rather than a single viral product.
Founded in 1980 by Elliott Balbert, the company gradually developed from a nutritional supplement business into a major consumer wellness brand. Its strongest position emerged around sleep and melatonin.
The company expanded internationally, built extensive retail distribution and developed consumer-friendly formats such as fast-dissolve tablets and gummies.
Aurobindo Pharma acquired Natrol in 2014 and later sold the business in 2020 to New Mountain Capital and Jarrow Formulas for $550 million. At the time of the transaction, Natrol had reported $156.66 million in annual revenue for the fiscal year ending March 31, 2020.
Natrol and Jarrow subsequently became part of Vytalogy Wellness, giving the brand access to a broader wellness platform and U.S. manufacturing infrastructure.
Today, Natrol remains heavily associated with melatonin. Its current product range includes fast-dissolve tablets, gummies, time-release formulas and other sleep-support products. The brand’s own 2026 materials cite Nielsen data supporting its position as the No. 1 melatonin brand in the United States.
Its marketing has also evolved. Instead of selling melatonin purely as a sleep supplement, Natrol increasingly sells a broader idea of better nights, better recovery and better wellness, using partnerships involving fitness, celebrities and major sleep-focused platforms such as Calm.
That may ultimately be the biggest reason Natrol has remained so strong.
It does not simply sell melatonin.
It has spent more than four decades teaching consumers to associate the Natrol name with sleep support.
And in a supplement market where thousands of brands compete for attention, that kind of category recognition can be more valuable than another new ingredient or another higher-dose formula.